Physician profile
Grant D Clinkingbeard
NPI 1710446968
$628.05
in general payments reported to CMS, 2019-2025
17 companies · $154 in 2025
The $154 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $53.07 · 2023: $103 · 2024: $318 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $574.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $198.47 | 2023-2024 | |
| Glaxosmithkline, LLC. | $85.54 | 2023-2025 | Shingrix, Arexvy, Bexsero |
| Pfizer INC. | $58.73 | 2025 | |
| Novo Nordisk INC | $35.23 | 2024-2025 | Wegovy, Rybelsus, Ozempic |
| Cranial Technologies, INC | $29.08 | 2024 | Doc Band |
| Regeneron Healthcare Solutions, INC. | $29.00 | 2022-2023 | Dupixent |
| Sanofi-Aventis U.S. LLC | $21.09 | 2024 | |
| Aerin Medical INC. | $20.93 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $20.14 | 2023 | |
| Verrica Pharmaceuticals INC. | $19.83 | 2025 | Ycanth |
| Itamar Medical INC | $19.10 | 2022 | |
| Phadia US INC. | $18.82 | 2025 | Immunocap |
| Amgen INC. | $15.45 | 2024 | Prolia, Evenity |
| Hikma Pharmaceuticals USA | $14.84 | 2023 | Ryaltris |
| Neurelis, INC. | $14.40 | 2024 | Valtoco |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $13.81 | 2024 | Farxiga |
| Cook Medical LLC | $13.59 | 2023 | Biodesign |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grant Clinkingbeard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.